It should also be noted that Bjorklund et al. used gene delivery of α-synuclein in their models, which produces α-synuclein levels 8–10 times that typically seen in Parkinson’s disease patients (Decressac et al., 2011). This evidence concerns the gene SNCA and Parkinson disease.